Latest / Making it in Manufacturing
CPHI Milan 2026 Newsbeat: 53Biologics Takes Fill And Finish Fully In House - Javier Santos
53Biologics is adding new lyophilisation equipment and an isolator to its facilities, completing its fill and finish capabilities so the company is fully end to end. That means the small batches first clinical trials need can stay under one roof.
On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Javier Santos, Business Developer at 53Biologics, about the company's new in-house lyophilisation and what it means for customers' clinical programmes.
In this episode, Javier covers:
(00:33) 53Biologics' new lyophilisation equipment and isolator, which complete its fill and finish…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.